Product Price :Get Latest Price
Product Details:Minimum Order Quantity | 1 Piece |
Drug Name | Meflotas 250mg |
Dosage Form | Tablet |
Packaging Size | 2 Tablets |
Packaging Type | Strips |
Product Type | Finished |
Dose | 250 mg |
Product Price :Get Latest Price
Product Details:Dosage Form | Tablet |
Packaging Size | 10 Tablets |
Packaging Type | Strips |
Dose | 25 mg,500 mg |
Product Type | Finished |
Chloroquine is very dangerous in overdose. It is rapidly absorbed from the gut. In 1961, published studies showed three children who took overdoses died within 2.5 hours of taking the drug. While the amount of the overdose was not cited, the therapeutic index for chloroquine is known to be small.
Symptoms of overdose include a headache, drowsiness, visual disturbances, nausea and vomiting, cardiovascular collapse, seizures, and sudden respiratory and cardiac arrest.
It has been found that certain strains of P. falciparum have become resistant to 4-aminoquinoline compounds (including chloroquine and hydroxychloroquine). Chloroquine resistance is widespread and, at present, is particularly prominent in various parts of the world including sub-Saharan Africa, Southeast Asia, the Indian subcontinent, and over large portions of South America, including the basin.
Complete blood cell counts should be made periodically if patients are given prolonged therapy. If any severe blood disorder appears which is not attributable to the disease under treatment, discontinuance of the drug should be considered.
The drug should be administered with caution to patients having a G-6-PD (glucose-6 phosphate dehydrogenase) deficiency.
Auditory EffectsIn patients with preexisting auditory damage, chloroquine should be administered with caution. In case of any defects in hearing, chloroquine should be immediately discontinued, and the patient closely observed (see Adverse Reactions).Explore More Products
3.4/5
Rated by 57 Users
© Medical Bureau. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited